Precipio, Inc. (NASDAQ:PRPO) Director Richard A. Sandberg Sells 2,000 Shares

Precipio, Inc. (NASDAQ:PRPO - Get Free Report) Director Richard A. Sandberg sold 2,000 shares of the firm's stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $6.28, for a total value of $12,560.00. Following the sale, the director now owns 16,525 shares of the company's stock, valued at $103,777. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Precipio Stock Up 2.3 %

Shares of Precipio stock opened at $6.14 on Wednesday. The business has a 50-day moving average of $6.47 and a 200-day moving average of $5.89. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.73. Precipio, Inc. has a 1-year low of $4.31 and a 1-year high of $8.49.

Precipio (NASDAQ:PRPO - Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The biotechnology company reported ($0.83) EPS for the quarter. Precipio had a negative return on equity of 34.01% and a negative net margin of 17.23%. The firm had revenue of $4.44 million during the quarter.

Precipio Company Profile

(Get Free Report)


Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.
I believe we are about to do it again with this new AI project called Stargate


Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.

Further Reading

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Precipio?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Precipio and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles